CIK: 0001372218 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $398,243 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRCT | PROCEPT BIOROBOTICS CORP | 5,328,867 | $221,361 | 55.6% | $38.38 | +11.9% | COM | 74276L105 |
| — | REATA PHARMACEUTICALS INC | 2,896,901 | $110,053 | 27.6% | $31.64 | — | CL A | 75615P103 |
| — | APOLLO ENDOSURGERY INC | 6,183,603 | $61,651 | 15.5% | $6.31 | — | COM | 03767D108 |
| — | INSTIL BIO INC | 8,218,467 | $5,178 | 1.3% | $25.08 | — | COM | 45783C101 |